Behavioral Finance | Multibagger Shares

April 26, 2026

Horizontal bar chart of Inventory Turnover Ratio by fiscal year (FY20–FY25): FY20 28, FY21 26, FY22 22, FY23 18, FY24 14, FY25 11. Declining trend in asset productivity.

Inventory Turnover Ratio: The Asset-Productivity Metric That Reveals Operating Discipline

Inventory Turnover (COGS ÷ Average Inventory) is the most diagnostic working-capital metric on any Indian annual report — high turnover means each rupee of stock generates more sales, falling turnover often warns of an earnings shock 12–18 months in advance. Titan Biotech FY25's ~103% CFO/Operating Profit, sequential QoQ revenue lift, and ~₹3 Cr borrowings illustrate disciplined inventory management in a long-cycle biotech manufacturer.

April 26, 2026

Infographic title 'The Too-Hard Pile' with a horizontal bar chart showing values FY20–FY25, declining from 28 to 11 (FY25 in green).

The Too-Hard Pile: Charlie Munger’s Cognitive-Humility Discipline for Indian Value Investors

Charlie Munger's three-box discipline — In, Out, Too Hard — is the cognitive-humility skill that separates serious investors from confident commentators. Titan Biotech FY25's legible filings illustrate the opposite of a too-hard company.

April 25, 2026

Hero image with the title 'System 1 vs System 2 Thinking' and a 2x2 color grid: top-left Lucky (gray), top-right Disciplined Investor (green), bottom-left Confused (light gray), bottom-right Bias-Trapped (orange) on a dark blue background.

System 1 vs System 2 Thinking: Daniel Kahneman’s Dual-Process Framework for Indian Long-Term Investors

Kahneman's dual-process theory unpacked for Indian retail investors: why System 1 hijacks portfolios, how Buffett, Munger, Klarman, and Marks engineer System 2, and how Titan Biotech's FY25 audited disclosures (₹3 Cr borrowings, 103% CFO/OP, 36.4% board independence) illustrate System-2-style management process.

April 25, 2026

Site hero with a dark blue background, large white title 'DuPont Three-Factor Decomposition of RoE' and green subtitle, centered multicolor donut chart labeled FY25 Reinvented.

DuPont Three-Factor Decomposition of RoE: How to See Through the Most Misunderstood Ratio in Indian Investing

RoE without the DuPont decomposition is a meaningless headline. Two companies with identical 25% RoE can be a fortress compounder and a leveraged time bomb. Today's lesson teaches the framework using Titan Biotech FY25 audited numbers as a positive illustration.